Skip to main content

Grand Challenges

Bill & Melinda Gates Foundation

Main menu

  • About
  • Challenges
  • Awarded Grants
  • News
  • Grant Opportunities
  • Search

You are here

  1. Home
  2. Awarded Grants

Print link

Print

Innovative 3D In Vitro Culturing System for Filarial Worms

Grand Challenges ExplorationsNeglected Tropical Diseases5 Apr 2013

Sara Lustigman of the New York Blood Center in the U.S. will develop a three-dimensional in vitro culturing system to support the development of infective larvae of parasitic filarial worms through to adulthood. Currently adult filarial worms can only be isolated in limited numbers from infected humans or animals, which precludes high throughput drug screening. The team will build three-dimensional cultures by testing different synthetic scaffolds with defined cell types in order to more closely mimic the human lymphatic vessels and nodules where these parasites normally reside, thereby encouraging their long-term growth. This will provide the greater numbers needed to screen for drugs that specifically kill adult worms, which are needed to eliminate this common and debilitating group of diseases.

More information about New Approaches in Model Systems, Diagnostics, and Drugs for Specific Neglected Tropical Diseases (Round 10)

Share This Awarded Grant

  • Twitter logo Twitter
  • Facebook logo Facebook
  • LinkedIn logo LinkedIn
  • Google+ logo Google+
  • Mailto logo Mailto

Principal Investigator

Sara Lustigman

Organization

New York Blood Center

Location

New York, New York
United States

Contact us

Contact us

  • General Inquiries
  • Media Inquiries

Footer - Receive Updates

Receive updates

  • Sign up for email updates

Footer

  • Privacy Policy and Terms of Use
© 2003-2019. Grand Challenges. All Rights Reserved.

PLEASE REVIEW OUR UPDATED PRIVACY & COOKIES NOTICE

This site uses cookies and similar technologies to store information on your computer or device. By continuing to use this site, you agree to the placement of these cookies and similar technologies. Read our updated Privacy & Cookies Notice to learn more.